Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Will Leqembi’s primary benefit—a slight slowing of decline in cognition and functioning—make a difference to patients and family members...
Ruxolitinib might have contributed to a functional cure after a stem cell transplant without a rare mutation.
The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.
A large clinical trial found that daily multivitamins led to modest improvements in memory over a three-year period.
People with HIV who added dolutegravir and maraviroc did not see an improvement in overall cognitive function.
Findings from NIH study offer insight into biological mechanisms, pointing to possible treatments.
Researchers encourage additional studies to determine why Black and Latino people experience long COVID symptoms more than white people.
Findings from small NIH study could provide insight into long-term neurological symptoms of COVID-19.
However, people who are not successfully treated may continue to experience declines in mental health.
Fatigue was associated with poorer performance on cognitive tasks related to processing speed but not learning ability.
The higher rate of post-COVID symptoms in older adults is likely due to a higher incidence of chronic disease and physical vulnerability.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Over-stimulated immune system may be impetus to cognitive symptoms, USCF-led study shows.
Often misdiagnosed. Almost always misunderstood. Alzheimer research is plagued with both myopic thinking and a vexing natural history.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.